National Research Tomsk Polytechnic University, Liu Yongsheng, Xu Tianqi, Vorobjeva A. G. Anzhelika Grigorjevna, Loftenius Annika, Bodenko V. V. Vitalina Vasiljevna, . . . Tolmachev V. M. Vladimir Maksimilianovich. (2023). Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - iss. 9. 2023. https://doi.org/10.3390/cancers15092409
Цитирование в стиле Чикаго (17-е изд.)National Research Tomsk Polytechnic University, Liu Yongsheng, Xu Tianqi, Vorobjeva A. G. Anzhelika Grigorjevna, Loftenius Annika, Bodenko V. V. Vitalina Vasiljevna, Orlova A. M. Anna Markovna, Frejd Y. F. Fredrik, и Tolmachev V. M. Vladimir Maksimilianovich. Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - Iss. 9. 2023, 2023. https://doi.org/10.3390/cancers15092409.
Цитирование MLA (9-е изд.)National Research Tomsk Polytechnic University, et al. Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - Iss. 9. 2023, 2023. https://doi.org/10.3390/cancers15092409.